scanX
Home
Smruthi Organics

Smruthi Organics

135.60
-5.00
(-3.56%)
Market Cap (₹ Cr.)
₹161
52 Week High
218.80
Book Value
₹
52 Week Low
139.00
PE Ratio
426.06
PB Ratio
2.31
PE for Sector
41.91
PB for Sector
22.12
ROE
6.06 %
ROCE
8.38 %
Dividend Yield
1.07 %
EPS
₹0.33
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-9.51 %
Net Income Growth
-13.09 %
Cash Flow Change
458.06 %
ROE
-14.91 %
ROCE
13.16 %
EBITDA Margin (Avg.)
34.47 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
25
17
16
18
23
20
18
20
23
18
27
22
31
29
29
39
41
33
38
35
30
29
37
32
29
31
31
37
36
29
43
32
37
35
30
23
40
27
Expenses
21
15
14
16
17
17
17
17
18
16
25
19
35
25
25
34
36
28
33
30
25
24
28
24
23
26
26
30
32
27
39
30
35
30
25
25
36
27
EBITDA
3
2
2
2
5
2
1
3
5
2
2
3
-4
4
4
5
5
5
5
5
5
6
9
8
6
5
5
6
4
2
4
2
2
5
4
-1
4
0
Operating Profit %
13 %
13 %
8 %
8 %
21 %
10 %
4 %
9 %
18 %
9 %
7 %
14 %
-14 %
12 %
11 %
11 %
11 %
15 %
12 %
3 %
17 %
19 %
25 %
26 %
19 %
14 %
15 %
16 %
10 %
6 %
9 %
5 %
6 %
13 %
15 %
-5 %
10 %
2 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
Interest
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
1
-0
-1
-1
3
0
-1
1
3
-0
0
1
-6
2
2
3
3
3
3
3
3
4
8
7
5
3
4
5
3
1
3
0
1
3
3
-3
2
-1
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
1
1
1
1
1
2
2
1
1
1
1
1
0
1
0
0
1
1
-1
1
0
Net Profit
3
-0
-1
-1
2
0
-1
1
2
-0
0
1
-5
2
1
2
2
2
2
2
2
3
6
5
3
3
3
4
2
0
3
0
1
2
2
-2
2
-1
EPS in ₹
8.53
-0.40
-1.35
-1.93
5.58
0.70
-2.90
1.32
5.04
-0.36
0.73
3.43
-12.22
4.03
2.70
6.09
4.95
5.79
4.97
6.35
5.04
7.82
15.31
13.39
2.77
2.21
2.33
3.01
1.51
0.26
2.44
0.10
0.60
2.00
1.81
-2.00
1.33
-0.81
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
109
103
85
85
101
88
92
88
106
118
Fixed Assets
35
32
30
30
30
32
31
33
37
40
Current Assets
47
44
44
51
65
53
59
53
65
75
Capital Work in Progress
1
1
1
1
2
0
1
1
2
1
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
72
70
54
54
69
56
60
53
66
77
Total Liabilities
79
72
53
56
65
45
31
20
37
49
Current Liabilities
44
41
42
48
57
38
25
16
35
42
Non Current Liabilities
35
32
11
9
7
7
7
5
2
7
Total Equity
29
31
32
29
36
42
60
67
68
70
Reserve & Surplus
26
27
28
25
33
39
49
56
57
58
Share Capital
4
4
4
4
4
4
11
11
11
11
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Cash Flow
-1
-0
0
0
2
-1
13
-3
0
Investing Activities
-1
0
-0
-3
-4
-5
-3
7
-10
Operating Activities
9
14
9
5
12
21
23
2
12
Financing Activities
-8
-14
-9
-2
-5
-17
-7
-12
-2
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
63.39 %
63.39 %
63.39 %
63.39 %
63.39 %
63.51 %
63.51 %
63.51 %
63.58 %
63.58 %
63.58 %
63.60 %
63.84 %
63.87 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
36.61 %
36.61 %
36.61 %
36.61 %
36.61 %
36.49 %
36.49 %
36.49 %
36.42 %
36.42 %
36.42 %
36.40 %
36.16 %
36.13 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,910.05 4,59,136.75 43.54 49,887.17 12.06 9,648 42.62 65.70
Divis Laboratories
5,425.55 1,44,114.94 86.09 8,184.00 0.89 1,600 20.79 63.34
Cipla
1,623.30 1,33,733.09 30.09 26,520.66 14.17 4,155 17.77 47.50
Dr Reddys Laboratories
6,633.25 1,12,386.62 20.19 28,905.40 12.36 5,578 -0.90 43.03
Zydus Life Science
1,057.35 1,07,551.32 25.80 19,831.50 13.82 3,831 30.78 36.39
Mankind Pharma
2,611.65 1,01,378.99 51.66 10,615.63 19.57 1,942 9.89 58.64
Lupin
2,198.25 99,598.89 44.00 20,141.50 19.94 1,936 77.69 52.72
Aurobindo Pharma
1,466.05 85,418.13 23.81 29,559.25 17.55 3,169 61.17 42.40
Alkem Laboratories
6,194.15 73,643.07 34.26 12,978.42 9.84 1,811 91.18 56.20
Glenmark Pharmaceuticals
1,662.70 46,424.18 - 12,653.09 6.58 -1,831 96.52 49.66

Corporate Action

Technical Indicators

RSI(14)
Neutral
30.84
ATR(14)
Volatile
5.35
STOCH(9,6)
Oversold
19.02
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-0.79
ADX(14)
Weak Trend
10.72
UO(9)
Bearish
41.56
ROC(12)
Downtrend And Accelerating
-7.27
WillR(14)
Oversold
-84.06
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.